Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Current Assets (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Current Assets for 16 consecutive years, with $468.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Assets rose 16.42% to $468.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $468.2 million, a 16.42% increase, with the full-year FY2025 number at $468.2 million, up 16.42% from a year prior.
  • Current Assets was $468.2 million for Q4 2025 at Lemaitre Vascular, up from $452.0 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $468.2 million in Q4 2025 to a low of $90.0 million in Q2 2021.
  • A 5-year average of $228.9 million and a median of $178.3 million in 2023 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: dropped 2.01% in 2021, then surged 106.68% in 2024.
  • Lemaitre Vascular's Current Assets stood at $139.9 million in 2021, then rose by 15.62% to $161.7 million in 2022, then grew by 20.32% to $194.6 million in 2023, then skyrocketed by 106.68% to $402.2 million in 2024, then grew by 16.42% to $468.2 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Current Assets are $468.2 million (Q4 2025), $452.0 million (Q3 2025), and $430.1 million (Q2 2025).